Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effects of Micronized Trans-resveratrol Treatment on Polycystic Ovary Syndrome (PCOS) Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2012 by Poznan University of Medical Sciences.
Recruitment status was:  Not yet recruiting
Sponsor:
Collaborator:
University of California, Davis
Information provided by (Responsible Party):
Beata Banaszewska, Poznan University of Medical Sciences
ClinicalTrials.gov Identifier:
NCT01720459
First received: October 31, 2012
Last updated: November 1, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)